Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Giorgia Melli MD, PhD

Prof. Giorgia Melli MD, PhD

Faculty of Biomedical Sciences, Università della Svizzera Italiana; Neurodegenerative Diseases Group, Laboratories for Translational Research, Neurocenter of Southern Switzerland EOC, Lugano, Switzerland

Prof Dr.med Giorgia Melli is the group leader of the Neurodegenerative disease Laboratory at Neurocenter of Southern Switzerland (NSI-EOC). She obtained the MD degree and the residency in neurology at the University of Parma, Italy in 2000. During her PhD in neuroscience, she completed a 3 year-research fellowship at Johns Hopkins University, Baltimore, USA, where she investigated mechanisms of axonal degeneration in cell cultures and animal models of peripheral neuropathies. Since 2013 she serves as neurologist at NSI-EOC, where she established the skin biopsy as diagnostic tool for the Neurology Department and is responsible for translational projects in Parkinson’s disease. She leads a multidisciplinary team devoted to biomarkers discovery in peripheral tissues in PD, bringing together clinicians, experts in movements disorders, bioengineers, and basic scientists.